Author

Gauri G. Rao

University of North Carolina at Chapel HillORCID 0000-0002-8704-7770Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:statistical model· 2 Organism:bacteria (other)· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Fernando G. PasterániD· 2 shared María Soledad RamireziD· 2 shared Rajnikant SharmaiD· 2 shared Ramya MahadevaniD· 2 shared Robert A. BonomoiD· 2 shared Ahmed Elsheikh· 1 shared Alan A. SchmalstigiD· 1 shared Alejandra C. CorsoiD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

Fernando G. PasteránORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Pharmacology & ToxicologyMolecular PharmaceuticsPeer-reviewedSep 17, 2026

Pharmacokinetics and Physiologically Based Pharmacokinetic Modeling of Mycobacteriophages: Insights into Pulmonary Distribution and Clearance

Rajnikant Sharma, Ramya Mahadevan, Sai Divyash…·Gauri G. Rao

The paper studies pharmacokinetics of mycobacteriophages in mice and develops a PBPK model to predict their distribution and clearance, showing that inhalation improves lung exposure.

1 citation

mousestatistical model

𝕏 PostBluesky

Pharmacology & ToxicologyAntimicrobial Agents and ChemotherapyPeer-reviewedDec 19, 2025

A Mechanism Based Pharmacokinetic/Pharmacodynamic Analysis of Polymyxin B-Based Combination Therapy Against Carbapenem-Resistant Klebsiella pneumoniae Isolates with Diverse Phenotypic and Genotypic Resistance Mechanisms

Ramya Mahadevan, Estefany Garcia, Rajnikant Sharma…·Gauri G. Rao

This study develops a mechanism-based pharmacokinetic/pharmacodynamic model to evaluate PMB-based combination therapy against CRKP, showing synergistic effects with lower PMB doses.

5 citations

humanstatistical model

𝕏 PostBluesky

MicrobiologyJournal of Global Antimicrobial ResistancePeer-reviewedJul 15, 2025

Emerging Resistance to Novel -βLactam β-Lactamase Inhibitor Combinations in Klebsiella pneumoniae bearing KPC Variants

Mase Hamza, German Matias Traglia, Lucía Maccari…·Maria Soledad Ramirez

This study identifies emerging resistance in KPC variants of K. pneumoniae to CZA, FDC, and FPZ, with mutations in specific regions linked to collateral resistance.

21 citationstop 2%

bacteria (other)experimental assay

𝕏 PostBluesky